Asia PR News

BASEL, May 30 /PRNewswire-Asianet/ –

Developing Oncology Solutions

Friday, 2 June 2006 (9:00 a.m. - 1:00 p.m.)
Atlanta Marriott Marquis Hotel
(For Non-U.S. Journalists Only)

WHAT: Exclusive preview of Roche worldwide oncology franchise’s
ground-breaking data.

Don’t miss this unique opportunity to hear first-hand about the
latest targeted and innovative therapies:

* Avastin: first anti-angiogenic agent for breast, colorectal and
non-small cell lung cancer

* Bondronat: only single nitrogen bisphosphonate for metastatic
bone disease

* Herceptin: first biologically engineered, monoclonal antibody
to treat breast cancer

* Mabthera: the world’s first monoclonal antibody therapy for the
treatment of non-Hodgkin’s lymphoma

* Tarceva: only EGFR-inhibitor with a survival benefit in lung
cancer

* Xeloda: unsurpassed patient convenience with an oral
chemotherapy regimen for breast and colorectal cancers

WHY: — Preview the latest cancer data from one of the world’s
premiere oncology portfolios

— Access to leading oncology experts and Roche senior executives
in a one-to-one interview format, immediately following the
Media Fair

WHERE: Atlanta Marriott Marquis Hotel
Marquis Ballroom, Salon 3 (Media Fair Exhibit) & Consulate Room
(Key Data Presentations) 265 Peachtree Avenue; Atlanta, Georgia
USA

WHEN: Friday, 2 June 2006 (9:00 a.m. to 1:00 p.m.)

RSVP: To register for this event and to arrange one-to-one interviews,
please contact Mitti Bose, Shire Health International via phone
at +1-212-625-7140, mobile +1-917-804-9084 or via e-mail at
mitti.bose@newyork.shirehealth.com We suggest you register
prior to June 2 to secure you’re spot at the briefing, however on-
site registration will be available with a press
badge/identification.

SOURCE: Roche